These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 825588)
1. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics. Finland M; Garner C; Wilcox C; Sabath LD J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains. Reyonolds AV; Hamilton-Miller JM; Brumfitt W J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics. Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591 [TBL] [Abstract][Full Text] [Related]
4. Gentamicin and amikacin---an in vitro comparison using 1000 clinical isolates. Forgan-Smith WR; McSweeney RJ Aust N Z J Med; 1978 Aug; 8(4):383-6. PubMed ID: 282852 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin. Yourassowsky E; Schoutens E; Vanderlinden MP Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457 [TBL] [Abstract][Full Text] [Related]
6. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns. Acar JF; Witchitz JL; Goldstein F; Talbot JN; Le Goffic F J Infect Dis; 1976 Nov; 134 SUPPL():S280-5. PubMed ID: 825587 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria. DiPersio JR; Krafczyk TL Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428 [TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin. Knothe H J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585 [TBL] [Abstract][Full Text] [Related]
9. Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates. Jones RN; Barry AL; Fuchs PC; Gavan TL; Sommers HM; Gerlach EH Antimicrob Agents Chemother; 1979 Dec; 16(6):823-8. PubMed ID: 533262 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides. Watanakunakorn C; Kauffman CA Infection; 1978; 6(3):111-5. PubMed ID: 98451 [TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition. Linzenmeier G; Naumann P; Neussel H; Rosin H J Infect Dis; 1976 Nov; 134 SUPPL():S262-70. PubMed ID: 825584 [TBL] [Abstract][Full Text] [Related]
12. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance]. Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424 [TBL] [Abstract][Full Text] [Related]
13. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin. Reynolds AV; Hamilton-Miller JM; Brumfitt W Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of netilmicin, gentamicin, and amikacin. Kantor RJ; Norden CW Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104 [TBL] [Abstract][Full Text] [Related]
15. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates. Price KE; DeFuria MD; Pursiano TA J Infect Dis; 1976 Nov; 134 SUPPL():S249-61. PubMed ID: 62814 [TBL] [Abstract][Full Text] [Related]
16. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria. Moellering RC; Wennersten C; Kunz LJ; Poitras JW Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ]. Kosakai N; Oguri T Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047 [TBL] [Abstract][Full Text] [Related]
18. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms. Rahal JJ; Simberkoff MS; Kagan K; Moldover NH Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics. Kelly MT; Matsen JM Antimicrob Agents Chemother; 1976 Mar; 9(3):440-7. PubMed ID: 1259402 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)]. Drugeon HB; Courtieu AL Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]